Allscripts Healthcare (NASDAQ:MDRX) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.15 by 20 percent. This is a 21.74 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $150.90 million which beat the analyst consensus estimate of $147.33 million by 2.42 percent. This is a 59.62 percent decrease over sales of $373.70 million the same period last year.
Allscripts Healthcare Q2 EPS $0.18 Beats $0.15 Estimate, Sales $150.90M Beat $147.33M Estimate
Allscripts Healthcare (NASDAQ:MDRX) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.15 by 20 percent. This is a 21.74 percent decrease over earnings of $0.23 per share from
Related Posts
Cantor Fitzgerald Maintains Overweight on Curaleaf Holdings, Lowers Price Target to $16.5
Cantor Fitzgerald analyst Pablo Zuanic maintains Curaleaf Holdings (OTC:CURLF) with a Overweight and lowers the price target from $18.5 to $16.5.
Nelnet’s Return On Capital Employed Insights
Pulled from Benzinga Pro data, Nelnet (NYSE:NNI) posted Q2 earnings of $82.90 million, an increase from Q1 of 55.16%. Sales dropped to $345.24 million, a 28.31% decrease between quarters.
Watching Non Fungible Token-Sensitive Stocks; Traders Circulate Earlier Tweet From VeVe ‘Disney magic is coming to VeVe! In celebration of @DisneyPlusDay, @Disney & VeVe are collaborating to launch a series of digital collectibles featuring beloved cha…
https://twitter.com/veve_official/status/1453408888355700738?s=20https://twitter.com/veve_off